Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Neurodevelopment Approach for a Transitional Model of Early Onset Schizophrenia
Domenico De Berardis, Sergio De Filippis, Gabriele Masi, et al.
Brain Sciences (2021) Vol. 11, Iss. 2, pp. 275-275
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Neuropsychological Profile, Emotional/Behavioral Problems, and Parental Stress in Children with Neurodevelopmental Disorders
Francesca Felicia Operto, Daniela Smirni, Chiara Scuoppo, et al.
Brain Sciences (2021) Vol. 11, Iss. 5, pp. 584-584
Open Access | Times Cited: 56
Negative symptoms in children and adolescents with early-onset psychosis and at clinical high-risk for psychosis: systematic review and meta-analysis
Gonzalo Salazar de Pablo, Ana Catalán, Julio Vaquerizo Serrano, et al.
The British Journal of Psychiatry (2023) Vol. 223, Iss. 1, pp. 282-294
Open Access | Times Cited: 25
Prediction of treatment response to antipsychotic drugs for precision medicine approach to schizophrenia: randomized trials and multiomics analysis
Liangkun Guo, Yi Su, Yuyanan Zhang, et al.
Military Medical Research (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 20
Identification and treatment of individuals with childhood-onset and early-onset schizophrenia
Christoph U. Correll, Celso Arango, Birgitte Fagerlund, et al.
European Neuropsychopharmacology (2024) Vol. 82, pp. 57-71
Open Access | Times Cited: 8
Novel missense variants in brain morphogenic genes associated with depression and schizophrenia
Maxim Karagyaur, A. L. Primak, Kirill Bozov, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 5
Brain Plasticity in Humans and Model Systems: Advances, Challenges, and Future Directions
Luca Bonfanti, Christine J. Charvet
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9358-9358
Open Access | Times Cited: 28
Autism Spectrum Disorder and Early Psychosis: a narrative review from a neurodevelopmental perspective
Silvia Guerrera, Maria Pontillo, Fabrizia Chieppa, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 4
Poly (I:C)‐induced maternal immune activation generates impairment of reversal learning performance in offspring
Eva Munarriz‐Cuezva, J. Javier Meana
Journal of Neurochemistry (2024) Vol. 169, Iss. 1
Open Access | Times Cited: 4
Understanding Autism as a Condition in Mental Health Clinical Practice: Clinical Perspectives from a Youth Early Psychosis Service
Cathryn Porter, Richard Whitehead, Liza Hopkins
Community Mental Health Journal (2025)
Open Access
The real-world impact of cariprazine on short- and long-term disability outcomes among commercially insured patients in the United States
Prakash S. Masand, Mousam Parikh, Jamie T. Ta, et al.
Journal of Medical Economics (2025), pp. 1-29
Open Access
Meta‐Analysis of Brain Structure in Magnetic Resonance Imaging Studies of Adolescents With Schizophrenia
Yang Mi, Di Kong, Jialong Huang, et al.
Mental Illness (2025) Vol. 2025, Iss. 1
Open Access
Schizophrenia: Antipsychotics and drug development
Gary Remington, Margaret Hahn, Sri Mahavir Agarwal, et al.
Behavioural Brain Research (2021) Vol. 414, pp. 113507-113507
Closed Access | Times Cited: 25
The Translational Future of Stress Neurobiology and Psychosis Vulnerability: A Review of the Evidence
Alexis E. Cullen, Javier Labad, Dominic Oliver, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 3, pp. 350-377
Open Access | Times Cited: 10
Antipsychotic utilization, healthcare resource use and costs, and quality of care among fee-for-service Medicare beneficiaries with schizophrenia in the United States
Pengxiang Li, Carmela Benson, Zhi Geng, et al.
Journal of Medical Economics (2023) Vol. 26, Iss. 1, pp. 525-536
Open Access | Times Cited: 10
Clinical and neurodevelopmental predictors of psychotic disorders in children and adolescents at clinical high risk for psychosis: the CAPRIS study
Montserrat Dolz, Jordina Tor, Olga Puig, et al.
European Child & Adolescent Psychiatry (2024) Vol. 33, Iss. 11, pp. 3925-3935
Closed Access | Times Cited: 3
Definition, assessment and treatment of cognitive impairment associated with schizophrenia: expert opinion and practical recommendations
Antonio Vita, Sergio Barlati, Roberto Cavallaro, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 3
Efficacy of Serotonin and Dopamine Activity Modulators in the Treatment of Negative Symptoms in Schizophrenia: A Rapid Review
Claudio Brasso, Gianluca Colli, Rodolfo Sgro, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 921-921
Open Access | Times Cited: 9
Hesperetin Ameliorates Inhibition of Neuronal and Oligodendroglial Cell Differentiation Phenotypes Induced by Knockdown of Rab2b, an Autism Spectrum Disorder-Associated Gene Product
Yukino Kato, Remina Shirai, Katsuya Ohbuchi, et al.
Neurology International (2023) Vol. 15, Iss. 1, pp. 371-391
Open Access | Times Cited: 7
Editorial: Comorbidity in bipolar disorder and schizophrenia, volume III
Giovanni Martinotti, Michele Fornaro, Domenico De Berardis
Frontiers in Psychiatry (2024) Vol. 14
Open Access | Times Cited: 2
Motion and Form Perception in Childhood-Onset Schizophrenia
Szabolcs Kéri, Ogúz Kelemen
Pediatric Reports (2024) Vol. 16, Iss. 1, pp. 88-99
Open Access | Times Cited: 2
Implications of SNP-triggered miRNA dysregulation in Schizophrenia development
Fadumo Abdullahi Mohamed, Kristine Freude
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 2
Comparative analysis of third-generation antipsychotics in first-episode schizophrenia: efficacy, safety, and cognitive impacts. A narrative review
Valerio Ricci, Alessandro Sarni, Giovanni Martinotti, et al.
International Clinical Psychopharmacology (2024)
Closed Access | Times Cited: 2
Effect of Group Cognitive Behavioral Therapy on Patients with Early-Onset Schizophrenia
Jing Hu, Bojing Geng, Yu Song, et al.
ALPHA PSYCHIATRY (2024) Vol. 25, Iss. 3, pp. 407-412
Open Access | Times Cited: 2
The transition from adolescence to adulthood in patients with schizophrenia: Challenges, opportunities and recommendations
Celso Arango, Jan K. Buitelaar, Christoph U. Correll, et al.
European Neuropsychopharmacology (2022) Vol. 59, pp. 45-55
Open Access | Times Cited: 11
Psychiatric rehabilitation patterns in Italy: Results from the Italian Society of Psychosocial Rehabilitation (SIRP) survey
Caterina Viganò, Cassandra Ariu, Deborah Barbieri, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top